Evidence map›Paper›PMID 41175176›Full record

ArticleEuropean journal of pediatrics2025

Altered tyrosine metabolism and B lymphocyte profiles are associated with disease severity in pediatric anti-NMDAR encephalitis: a cross-sectional study.

Dingding Cao, Min Zhang, Caihui Ma, Shengrong Ouyang, Hui Jiao, Shuo Miao, Zhao Liu, Guannan Li, Dongqing Li, Jing Sun and 1 more

Abstract read
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dingding Cao *Dept. of Biochemistry and Immunology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
Min Zhang *Dept. of Biochemistry and Immunology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
Caihui MaDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Shengrong OuyangDept. of Biochemistry and Immunology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
Hui JiaoDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Shuo MiaoDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Zhao LiuDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Guannan LiDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Dongqing LiDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Jing SunDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China.
Jianzhao ZhangDepartment of Neurology, Capital Center for Children's Health, Capital Medical University, Beijing, 100020, China. zjz18518387618@vip.163.com.

Funding

Beijing Research Ward Excellence Program BRWEP2024W102100103
6 · The paper itself

Abstract

The serum phenylalanine (Phe)/tyrosine (Tyr) ratio has recently been described as a potential prognostic biomarker for anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in adulthood; however, little is known about this phenomenon among children. As such, this study aimed to identify the characteristics of Phe and Tyr metabolism and specific immune cell subsets in children diagnosed with anti-NMDAR encephalitis. Clinical data from 24 patients diagnosed with anti-NMDAR encephalitis at the Capital Center for Children's Health, Capital Medical University, between January 2019 and March 2022, were retrospectively analyzed. Among children with anti-NMDAR encephalitis, blood levels of Tyr were decreased in those with sleep disorders and decreased consciousness. Blood Tyr levels and Phe/Tyr ratios were significantly associated with disease severity. In addition, the percentage of B lymphocytes was increased in patients with anti-NMDAR encephalitis, and there was a strong correlation between blood Tyr level, Phe/Tyr ratio, and the percentage of B lymphocytes. Furthermore, significant correlations were found between blood Tyr levels, Phe/Tyr ratio, percentage of B lymphocytes, and modified Rankin Scale and Glasgow Coma Scale scores.

conclusionBlood Phe and Tyr levels and lymphocyte subsets differed among children diagnosed with anti-NMDAR encephalitis. Blood levels of Tyr and the Phe/Tyr ratio were associated with the severity of neurological status and percentage of B lymphocytes. These findings highlight the importance of interactions between metabolism and immunity and their effects on neuronal function in the brain. WHAT IS KNOWN: • Elevated serum phenylalanine (Phe)/tyrosine (Tyr) ratio is associated with psychiatric syndrome and the severity of anti-NMDAR encephalitis in adulthood. • T lymphocyte subsets in the cerebrospinal fluid were different between adults with anti-NMDAR encephalitis and those with viral encephalitis. WHAT IS NEW: • Blood Tyr levels were decreased in anti-NMDAR encephalitis children with sleep disorders and decreased consciousness and were significantly associated with disease severity. • The percentage of B lymphocytes was increased in children with anti-NMDAR encephalitis, with a significant correlation between blood Tyr level, Phe/Tyr ratio, and the percentage of B lymphocytes.

Indexed as

Anti-N-Methyl-D-Aspartate Receptor EncephalitisB-LymphocytesPhenylalanineTyrosineAdolescentBiomarkersChildChild, PreschoolCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesSeverity of Illness IndexBiomarkersPhenylalanineTyrosineAnti-NMDAR encephalitisBiomarkerBlood Phe/Tyr ratioBlood tyrosineB lymphocyte

Identifiers

PMID41175176
PMCPMC12579682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.